Breaking: USFDA grants Remdesivir Emergency Use Authorization in COVID-19 Treatment Hina Zahid2 May 2020 10:42 AM ISTUSA: In a major development, the U.S. Food and Drug Administration has issued an emergency use authorization for the investigational antiviral...
Gilead eyes remdesivir supplies for 1 million patients by year end MD Bureau1 May 2020 1:25 PM ISTNew York: Amid positive results from two trials of investigational antiviral drug remdesivir on hospitalised COVID-19 patients, its US-based...
Examining remdesivir for treatment for Covid-19: Health Ministry MD Bureau30 April 2020 5:51 PM ISTRemdesivir met primary end goal in stage 3 trial
Breakthrough: Gilead's Investigational Antiviral Remdesivir shows positive results in Stage 3 trial in Patients With Severe COVID-19 Ruchika Sharma30 April 2020 1:41 PM ISTNo new safety signals were identified with remdesivir across either treatment group
Remdesivir has no significant clinical benefits in Covid 19: Lancet Dr. Kamal Kant Kohli29 April 2020 9:00 PM ISTA Lancet study has revealed that treatment with remdesivir did not speed recovery or reduce deaths from COVID-19 compared with placebo in hospitalised...
Remdesivir failed to produce desired results against Covid-19, says Chinese Trial; Gilead questions report MD Bureau24 April 2020 12:30 AM ISTGilead reacted to the results of the China study, saying that draft document included "inappropriate characterisations of the study" which is...
155 drugs and 79 vaccines in development to fight coronavirus Ruchika Sharma22 April 2020 4:23 PM ISTVienna: It seems as if the test tubes of this world currently only exist for coronaviruses – pharmaceutical and biotech companies, university...
Gilead shares hike in response to remdesivir trials in COVID-19 patients Ruchika Sharma18 April 2020 2:26 PM ISTUS: Gilead Sciences Inc's shares surged 16 percent in after-hours trading on Thursday following a media report detailing encouraging partial data from...
Antiviral drug Remdesivir, earlier used in Ebola, may hinder reproduction of coronavirus : ICMR Medical Dialogues Bureau14 April 2020 12:45 PM ISTAccording to a recently published study in the New England Journal of Medicine, two out of three critically ill coronavirus infected patients who were...
Experimental drug Remdesivir improves 68% COVID-19 patients: NEJM Study MD Bureau12 April 2020 8:02 PM ISTTreatment with remdesivir resulted in an improvement in oxygen support class for 36 of patients over a median follow-up of 18 days from the first dose...
Remdesivir improves 68% patients of severe Covid 19 in NEJM study Dr. Kamal Kant Kohli12 April 2020 12:04 AM ISTMore than two-thirds of severely ill COVID-19 patients, 68% to be precise improved after treatment with remdesivir, an experimental drug being...
EMA recommends compassionate use program of remdesivir for COVID-19 Dr. Kamal Kant Kohli5 April 2020 9:37 PM ISTThe European Medicines Agency (EMA) hss released a set of recommendations for providing investigational drug remdesivir under compassionate use...
